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Hypoxanthine production by ischemic heart demonstrated by high pressure liquid chromatography of blood purine nucleosides and oxypurines E. Harmsen *, J.W. 
Summary
An isocratic high pressure liquid chromatographic system was developed for the estimation of purine nucleosides and oxypurines in blood. Use was made of a reversed-phase column. Nucleotides derived from erythrocytes affected the separation; these compounds were removed with A120,. The recovery of the whole clean-up procedure exceeded 75%, and the lower detection limit of the assay for blood metabolites was 0.1 pmol/l. In 6 healthy volunteers, non-resting, the following blood concentrations (mean values t S.D. in pmol/l) were observed: adenosine (-c 0.1) inosine (0.2 + O.l), hypoxanthine (2.2 & 1.3) and xanthine (0.2 -+ 0.1). In plasma and serum the total amount of these compounds was 1.9 and 5.4 times higher, respectively, presumably due to nucleotide breakdown during blood processing. The myocardial arterial-venous differences of blood purine nucleosides, oxypurines and lactate were subsequently measured in blood samples from 13 patients with angiographically documented ischemic heart disease, undergoing an atria1 pacing stress test. No significant release of adenosine, inosine and xanthine by the heart was detectable in this study. The myocardial arterial-venous difference of lactate changed from 0.01 5 0.03 mmol/l (mean * SEM) at rest, to -0.10 -+ 0.04 mmol/l during pacing (p < 0.002). Relatively larger changes were observed for hypoxanthine:
pacing increased the arterial-venous difference from -0.01 -+ 0.05 to -0.5 1 -+ 0.17 pmol/l ( p < 0.02). We conclude that the high pressure liquid chromatographic assay of blood hypoxanthine is a useful tool in the diagnosis of ischemic heart disease.
Introduction
During and after hypoxia or ischemia, there is in the heart, as well as in other muscles, excessive ATP breakdown.
This degradation of ATP causes an efflux of breakdown products, which are able to pass through the cell membrane, and are released into the blood. The purine derivatives adenosine, inosine and hypoxanthine are thought to be markers for ischemia (for a review, see ref. [l] 
Materials and methods
Enzymes (X0, 13 U/ml; NP, 10 U/ml; ADA, 140 U/ml) were purchased from Blood sample treatment Blood (2.0 ml) was deproteinized immediately with an equal volume of HClO, as described by Remme et al. [2] . Plasma was prepared by adding 3 ml blood to a heparinized tube and immediate centrifugation for 15 min at 3000 X R (4°C). Serum was prepared from 3 ml blood which had been allowed to clot at room temperature for 30 min and subsequent centrifugation.
Plasma and serum were also deproteinized with equal volumes of HClO,. After centrifugation, the supernatant fluids were stored at -20°C.
The acid extracts were brought to pH 5-7 at 0°C with an automatic titration device (Radiometer, Copenhagen) using 150&200 ~1 6 mol/l KOH + 1 mol/l K,CO,. KClO, was spun down for 10 n-tin at 12000 X g at 4°C. For plasma and serum 200 ~1 of these extracts were directly injected onto the HPLC column. For whole blood extracts, removal of nucleotides appeared to be necessary. We used the method of Chatterjee et al. [9] , with some minor differences. We applied 1.5 ml of the deproteinized, neutralized blood sample onto a pre-washed column of Al,O, (0.6 g) in a Pasteur pipette, and eluted it with 5.0 ml 10 mmol/l Tris/HCl, pH 7.4. For faster elution, a vacuum was applied; with a 1225 sampling manifold (Millipore Co.) 12 samples were treated at the same time. With standards (about 10 pmol/l oxypurines and nucleosides, and about 5 mmol/l nucleotides), we found recoveries exceeding 90%, whereas the nucleotides were fully retained. These values are in close agreement with values in the literature [9] .
Recovev studies for blood treatment
To carry out recovery studies, it is necessary to inactivate first the purine metabolizing enzymes in the blood. We achieved this by rapid mixing of blood with cold HClO,. This procedure is comparable to the determination of recoveries after inactivation of enzymes by freeze-clamping heart tissue, or removal of cells from blood, and subsequent addition of standards [4,5,7,8,10-121. If radioactive standards were used 10 ~1 14C-labelled hypoxanthine, xanthine, inosine or adenosine were mixed with 10 ml HClO,. For the determination of radioactivity 50 ~1 aliquots were mixed with 10 ml Insta-gel (Packard Instr. Co., Downers Grove, IL. U.S.A.) and counted with a Packard Tricarb 2650 liquid scintillation counter. 
High pressure liquid chromatography

Lactate assay
Lactate was determined in acid supernatants in duplicate with an AutoAnalyzer II (Technicon, Tarrytown, NY, U.S.A.) as described by Apstein et al.
[ 141.
Statistical analysis
Statistical analysis in Table II was performed with a two-group comparison test based on Student's t distribution, and those in Table III and Fig. 5 by Student's paired t test. p-values < 0.05 (two-sided) were considered significant. Fig. 1 represents the separation of several nucleosides and purine bases. The lower detection limit with a 200 ~1 sample loop is 0.01 pmol/l; the method is linear up to 200 pmol/l (Fig. 2) . The standard deviation at the 10, 1 and 0.1 pmoljl level is < 0.1256, < 5% and < 9%, respectively (n = 9). Identification of the compounds in pre-purified blood samples was achieved by retention times (Fig. 3a) , cochromatography of standards (Fig. 3b ) and enzyme shifts (Fig. 3c) , as described by Hartwick et al. [7] . The clean-up procedure of the blood samples causes a 9-fold dilution, which increased the lower detection limit in blood to 0.1 ~mol/l. 
Results
HPLC
Recoveries
With radioactive standards the recoveries for the whole clean-up procedure exceeded 75% (Table I) . With non-radioactive standards, assayed by HPLC, we found comparable recoveries in the concentration range of our interest (Fig. 4) . 
Purine derivatives in blood, plasma and serum
Six healthy non-fasting, non-resting volunteers donated venous blood. In their blood, plasma and serum, hypoxanthine, xanthine, inosine and adenosine were determined.
The results are listed in Table II . As can be seen plasma shows 1.6 times higher levels of hypoxanthine and 5.5 times higher levels of xanthine than blood. Serum has significantly higher values of the AMP-catabolites.
Here the values are 2.5 times (for hypoxanthine) to 33 times (for xanthine) higher, compared to blood.
Determination of blood purine nucleosides, oxypurines and lactate of patients with ischemic heart disease
Thirteen patients with angina pectoris were catheterized as described by Remme et al. [2] . The patients were fasted overnight and 36 h before catheterization all medication was stopped. Before catheterization 50000 IE of heparin were infused. The diagnosis, ischemic heart disease, was established by angiography (obstruction of at least one coronary artery > 50%). Before angiography an atria1 pacing stress During a control period, maximal pacing, and 5 and 20 min after pacing, arterial and coronary sinus blood samples were taken. At rest no significant myocardial arterial-venous hypoxanthine or lactate difference was seen (Fig. 5) . During maximal pacing, a rise in coronary sinus hypoxanthine (from 0.83 to 1.43 pmol/l, p < 0.01) and lactate (from 0.87 to 0.98 mmol/l, p < 0.005) was observed, which fell off after pacing. The arterial levels of these compounds remained constant.
The myocardial arterial-venous difference of hypoxanthine changed from -0.01 pmol/l at rest to -0.5 1 pmol/l ( p < 0.02) during pacing (Table III) . We showed in earlier work [2, 15] that patients with angina1 pain, but with patent coronary arteries (< 50% obstruction), did not produce myocardial hypoxanthine.
Relatively smaller changes were observed for lactate: pacing in- creased the arterial-venous difference from 0.01 to -0.10 mmol/l ( p < 0.002, see Table III ). Significant production of lactate, calculated either as arterial-venous difference or extraction, only took place during maximal pacing, but significant hypoxanthine release was also present 5 min after pacing was stopped (Table III) . The coronary sinus levels of adenosine, inosine and xanthine during the control period were 0.17 -+ 0.04, 0.53 ? 0.11 and 0.20 k 0.14 pmol/l, respectively. No significant arterio-venous differences were observed throughout the test.
Discussion
Hypoxanthine, xanthine, inosine and adenosine levels in human blood (or plasma or serum) have been measured in normal adults [7] [8] [9] [10] [11] 161 (1) Differences in assay methods. The enzymatic determination of hypoxanthine, for instance, does not differentiate between hypoxanthine and xanthine. (2) As we have shown in Table II , large differences occur in the levels of these compounds when these are measured in blood, plasma or serum from the same person. These differences can be explained by the enzymatic degradation of ATP, derived from blood cells. and ADP, released from platelets during clotting [7, 8] . Furthermore xanthine, as the end-product of guanine nucleotide catabolism, can be expected to occur in higher concentrations in plasma and serum than in blood. For instance, blood xanthosine, guanosine and guanine are rapidly converted to xanthine [22] . For this reason instant inactivation by acid seems indicated, when one wants to determine the nucleoside and oxypurine concentration in the blood. (3) Physical activity also influences the levels of these AMP catabolites in blood. Sutton et al. [23] showed that the plasma levels of oxypurines are twice as high during and after physical training compared with control levels. Although they did not measure inosine levels in the plasma, urinary inosine during excercise is elevated tenfold, possibly indicating increased inosine levels in the blood. Therefore, if one wants to measure normal values, it is also important to define the physical state of the group under study.
We feel that measuring myocardial arterial-venous differences of blood hypoxanthine levels could give insight into the metabolic state of the heart; the method described here makes it possible to measure a number of purine metabolites in blood. The observations on the patients undergoing an atria1 pacing stress test indicate that hypoxanthine is a more sensitive parameter for myocardial ischemia than adenosine, inosine, xanthine or lactate, because hypoxanthine release is more pronounced and of a longer duration than that of the other compounds.
